Literature DB >> 14878108

Experimental therapy of onchocerciasis with suramin and hetrazan; results of a three-year study.

T A BURCH, L L ASHBURN.   

Abstract

Entities:  

Keywords:  ONCHOCERCIASIS/therapy

Mesh:

Substances:

Year:  1951        PMID: 14878108     DOI: 10.4269/ajtmh.1951.s1-31.617

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  7 in total

1.  Observations on the chemotherapy of onchocerciasis in Bahr el Ghazal Province, Sudan.

Authors:  M H SATTI; R KIRK
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

2.  Resistance of Onchocerca volvulus microfilariae to diethylcarbamazine.

Authors:  L VARGAS; J TOVAR
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

3.  From in vivo to in vitro: How the Guatemala STD Experiments Transformed Bodies Into Biospecimens.

Authors:  Kayte Spector-Bagdady; Paul A Lombardo
Journal:  Milbank Q       Date:  2018-04-13       Impact factor: 4.911

Review 4.  100 Years of Suramin.

Authors:  Natalie Wiedemar; Dennis A Hauser; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

5.  The effects of drugs on Onchocerca volvulus. 3. Trials of suramin at different dosages and a comparison of the brands Antrypol, Moranyl and Naganol.

Authors:  B O Duke
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

6.  Structural and functional characterization of suramin-bound MjTX-I from Bothrops moojeni suggests a particular myotoxic mechanism.

Authors:  Guilherme H M Salvador; Thiago R Dreyer; Antoniel A S Gomes; Walter L G Cavalcante; Juliana I Dos Santos; César A Gandin; Mário de Oliveira Neto; Márcia Gallacci; Marcos R M Fontes
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

7.  The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro.

Authors:  Raphael J Eberle; Danilo S Olivier; Marcos S Amaral; Ian Gering; Dieter Willbold; Raghuvir K Arni; Monika A Coronado
Journal:  Viruses       Date:  2021-05-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.